← Back to Search

Behavioral Intervention

Enhanced Contingency Management (CM+) for Substance Use Disorder

N/A
Waitlist Available
Research Sponsored by Oregon Social Learning Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 12 to 17 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This trial will help researchers understand what causes change in adolescent substance abuse treatment, so that future treatments can be more effective.

Who is the study for?
This trial is for teens aged 12 to 17 with a substance use disorder. A parent or guardian must be available to participate. It's not specified who can't join, but typically those with health issues that could interfere might be excluded.Check my eligibility
What is being tested?
The study compares two treatments for teen substance abuse: Standard Contingency Management (CM) and an enhanced version (CM+). The goal is to find out which elements are most effective in improving outcomes during and after treatment.See study design
What are the potential side effects?
Since the interventions involve behavioral therapy techniques rather than medications, typical medical side effects aren't expected. However, participants may experience emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 17 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes from Baseline scores compared to 12 months post-Baseline Youth Urine Drug/Alcohol Screens (measured at 0, 2, 4, 6, 9, & 12 months).
Secondary outcome measures
Changes from Baseline scores compared to 12 months post-Baseline Parent Contingency Management (CM) Adherence (measured at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, & 12 months).
Changes from Baseline scores compared to 12 months post-Baseline Parent Management (measured at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, & 12 months).
Changes from Baseline scores compared to 12 months post-Baseline Peer Relations (measured at 0, 2, 4, 6, 9, & 12 months).
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Contingency Management (CM+)Experimental Treatment1 Intervention
This group will receive an enhanced CM protocol for adolescent substance abuse that targets parenting more intensely.
Group II: Standard Contingency Management (CM)Active Control1 Intervention
This group will receive standard CM for adolescent substance abuse.

Find a Location

Who is running the clinical trial?

Oregon Social Learning CenterLead Sponsor
35 Previous Clinical Trials
10,645 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being accepted for this trial at the present time?

"Indeed, the details listed on clinicaltrials.gov indicate that this trial is actively enrolling patients. The research was first uploaded to the site on April 23rd 2018 and most recently updated on May 11th 2022. In total, 172 individuals are needed for participation at a single medical facility."

Answered by AI

Do I meet the requirements to participate in this therapeutic trial?

"To qualify for this trial, applicants must meet two criteria: a diagnosis of substance use disorder (SUD) and an age that falls between 12 years old to 17. The investigation is looking to include 172 individuals."

Answered by AI

How many participants are participating in this trial?

"Affirmative. Per the information available on clinicaltrials.gov, this medical investigation is currently in search of participants. The initial posting was made on April 23rd 2018 and most recently revised on May 11th 2022. A total of 172 patients need to be enrolled from a single site."

Answered by AI

Does this research protocol permit the inclusion of individuals aged twenty-five and above?

"According to the criteria for inclusion in this trial, minors aged 12-17 are eligible. 76 clinical trials have been designed with those under 18 years old as participants and 255 studies focus on individuals over 65."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Adolescent and Family Clinic, OSLC Developments, Inc.
What portion of applicants met pre-screening criteria?
Met criteria
~4 spots leftby Jul 2024